NCT05602727 Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008) Status TERMINATED Phase PHASE2
NCT05600309 A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Study Status COMPLETED Phase PHASE3
NCT05599789 Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05597839 Study of DF9001 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT05594043 A Study of MK-6598 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-6598-001) Status COMPLETED Phase PHASE1
NCT05592223 Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines Status COMPLETED Phase PHASE1
NCT05587712 Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008) Status RECRUITING Phase PHASE2
NCT05572684 A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT05569954 Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults 50 Years of Age or Older (V116-010, STRIDE-10) Status COMPLETED Phase PHASE3
NCT05562999 Impact of Deep Neuromuscular Blockade During Total Hip Replacement Surgery on Postoperative Recovery and Immune Function Status COMPLETED Phase PHASE4
NCT05562830 A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A) Status RECRUITING Phase PHASE1/PHASE2
NCT05562817 The Epidemiology , Health and Economic Burden of RSV Amongst Hospitalized Children Under 5 Years of Age in Jordan Status UNKNOWN Phase N/A
NCT05561764 Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis Status TERMINATED Phase PHASE4
NCT05559905 Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017) Status COMPLETED Phase PHASE2
NCT05558982 BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05557370 Immunogenicity of HPV Vaccine in Transplant Recipients. Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05555732 Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05548621 A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC) Status RECRUITING Phase N/A
NCT05545969 Neoadjuvant Pembrolizumab and Lenvatinib for Mucosal Melanoma Status WITHDRAWN Phase PHASE2